SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending following reports of a major initiative aimed at boosting the mortgage bond market and lowering interest rates to stimulate housing demand. This has ignited significant excitement among the community, which is actively discussing a potential short squeeze and a robust rebound for the real estate sector.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending following an FDA notification of deficiencies in its Anaphylm application, which has paused labeling discussions but is not a final decision. While some investors fear a significant delay or rejection, many view the substantial stock pullback as an overreaction, anticipating that the issues are minor and will be resolved prior to the upcoming PDUFA date. The community is actively debating whether this signals a major setback or a strategic opportunity for eventual approval of the innovative needle-free allergy treatment.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is trending due to a significant institutional investment, including a $1 billion stock and warrant sale priced above market, and its subsidiary Airobotics securing a prime contract for Israel's border security "Drone Hives" program. This has ignited strong community conviction, with many interpreting the premium paid and high warrant strike price as signals for substantial future appreciation in the autonomous defense sector, despite some discussions around short-term dilution.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending following a significant agreement with a major tech company to advance nuclear energy development for AI data centers. This partnership is energizing discussions, with many highlighting the critical role of advanced nuclear technology in meeting rising power demands, while others express skepticism over the company's current valuation and long development timeline.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is experiencing extreme volatility, fueled by recent natural gas storage reports and highly conflicting short-term weather forecasts. The community is sharply divided, with many expressing frustration over significant price declines and the ETF's 'widowmaker' reputation, while others view current levels as a key buying opportunity ahead of potential cold snaps.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is experiencing strong bullish momentum, primarily driven by housing policy announcements signaling lower mortgage rates and an anticipated refinance boom. The community is actively discussing RKT's strategic positioning, including its recent acquisitions, and speculating on technical breakouts and short squeeze potential, as the company is seen as a prime beneficiary of a normalizing housing market.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings Limited ($ANPA) is trending due to explosive price action, reminiscent of previous low-float Hong Kong IPOs. The community is actively debating whether this is a parabolic squeeze driven by a tightly held float or a classic pump and dump, with many comparing its extreme volatility to other recent "China plays." Despite discussions of a potential rug pull, investors are closely watching its unusual market behavior, fueling intense conversation around its rapid movements.

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.

Aptevo Therapeutics Inc

Aptevo Therapeutics (APVO) is trending following news of securing a $60 million equity line of credit, which some view as a critical funding boost for its pipeline while others fear it signals further dilution. The company's extremely low share float after a recent reverse split has ignited significant community discussion around a potential short squeeze, despite ongoing concerns about historical shareholder value and the nature of the new financing.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASP Isotopes is trending sharply following Meta's strategic push into nuclear energy, with investors specifically noting ASPI's partnership with TerraPower as a key catalyst. The community is also reacting to the completed Renergen acquisition and a new "Overweight" rating from Cantor Fitzgerald, fueling discussion around ASPI's diverse role in HALEU, advanced semiconductors, and medical isotopes. These developments position ASPI at the intersection of critical materials and a resurgent nuclear energy sector.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is experiencing renewed investor interest amidst a broader nuclear energy renaissance, fueled by accelerating demand from AI data centers and ongoing government support for small modular reactors. The community is actively debating its potential following a recent Bank of America upgrade and comparisons to peers like OKLO, which secured a significant power deal for Meta Platforms. Investors are balancing NuScale's unique NRC-approved technology against concerns around valuation and share supply from major holders, anticipating future contract announcements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PANTHERx Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*

PANTHERx Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, and Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical...

Savara (NASDAQ:SVRA) Shares Down 5.1% - Should You Sell?

Savara (NASDAQ:SVRA) Trading Down 5.1% - What's Next...

Savara Inc. (NASDAQ:SVRA) Short Interest Up 33.1% in December

Savara Inc. (NASDAQ:SVRA - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totaling 20,185,493 shares, an increase of 33.1% from the...

Swedbank AB Takes $1.96 Million Position in Savara Inc. $SVRA

Swedbank AB acquired a new stake in Savara Inc. (NASDAQ:SVRA - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor...

What is HC Wainwright's Forecast for Savara FY2027 Earnings?

Savara Inc. (NASDAQ:SVRA - Free Report) - Investment analysts at HC Wainwright upped their FY2027 earnings per share (EPS) estimates for shares of Savara in a research note issued on Tuesday...

FY2029 Earnings Estimate for Savara Issued By HC Wainwright

Savara Inc. (NASDAQ:SVRA - Free Report) - Stock analysts at HC Wainwright increased their FY2029 earnings per share (EPS) estimates for shares of Savara in a note issued to investors on Tuesday...

Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with...

Savara Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will present and host...

Savara Inc. (NASDAQ:SVRA) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Savara Inc. (NASDAQ:SVRA - Get Free Report) have received an average recommendation of "Moderate Buy" from the ten brokerages that are currently covering the company, Marketbeat.com...

Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI*

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the EPO notified the Company of its intention to grant a...

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Savara Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$5.76
Prev Close	$5.77
Open	$5.67
Dividend Yield	0.00%
50-Day Moving Average	$5.43
Beta	1.06
Avg. Volume	3.8M
PE Ratio	-10.76

52-Week High	$7.01
52-Week Low	$1.89
Market Capitalization	$1.17B
EPS (Annual)	-$0.4838
Price to Book	10.55
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

SVRA
Savara Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SVRA News

SVRASavara Inc